Who Attends

Engage and Network with 250+ Experts Pioneering the Gene Therapy Field

Well-established now as the industry-leading event for companies progressing gene therapies in the rare disease space through the clinic and towards approval, Gene Therapy for Rare Disorders is back for 2024, providing an unparalleled opportunity to engage in meaningful discussion with 250+ experts at the forefront of this field.  

 

100+ organizations joined us last time, including: 

NEW COMPANIES (1)

Interact with key gene therapy stakeholders, including:

Innovative Biotech

Large Pharma

Regulators

Government Officials

Investors

Patient
Groups

Academics

Service Providers

Attendee Breakdown:

Industry Breakdown
Attendee Breakdown

"The topics of the presentations were fully aligned with my needs and very valuable. I gained insights that I can implement immediately in my work"

UCB, 2023 Attendee